Skip to main content
. Author manuscript; available in PMC: 2024 Apr 1.
Published in final edited form as: J Cancer Educ. 2022 May 19;38(2):682–690. doi: 10.1007/s13187-022-02177-5

Table 2.

Changes in breast and cervical cancer screening and knowledge between baseline and 4-month follow-up, n=421

Education + Media + PN Arm, n=210 Education + Media Arm, n=211
Baseline, n (%) 4-month, n (%) p-value Baseline, n (%) 4-month, n (%) p-value
Mammogram Screening Uptake
Mammogram <2 years (age 40–75)) 33 (16.0) 101 (49.0) <0.001 30 (14.7) 91 (44.6) <0.001
Mammogram <2 years (age 50–74) 26 (19.6) 70 (52.6) <0.001 20 (16.1) 58 (46.8) <0.001
Mammogram <2 years or scheduled (age 40–75) 33 (16.0) 128 (62.1) <0.001 30 (14.7) 116 (56.9) <0.001
Mammogram <2 years or scheduled (age 50–74) 26 (19.6) 85 (63.9) <0.001 20 (16.1) 74 (59.7) <0.001
Pap Test Screening Uptake a
Pap test <3 years (age 40–75) 32 (16.9) 80 (42.3) <0.001 34 (17.3) 73 (37.1) <0.001
Pap test <3 years (age 40–65) 28 (17.0) 71 (43.0) <0.001 31 (18.7) 67 (40.4) <0.001
Pap test <3 years or scheduled (age 40–75) 32 (16.9) 95 (50.3) <0.001 34 (17.3) 84 (42.6) <0.001
Pap test <3 years or scheduled (age 40–65) 28 (17.0) 83 (50.3) <0.001 31 (18.7) 77 (46.4) <0.001
Cancer Knowledge
Breast cancer, mean (SD) 2.5 (1.7) 4.2 (0.9) <0.001 2.6 (1.6) 4.1 (0.9) <0.001
Cervical cancer, mean (SD) 2.2 (1.9) 4.6 (1.8) <0.001 2.4 (2.0) 4.5 (1.8) <0.001
a

Denominator does not include women who have received a hysterectomy.